About the Author(s)


Asmaa M. Zahran symbol
Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Hanaa Nafady-Hego symbol
Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt

Sawsan M. Moeen symbol
Department of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt

Hanan A. Eltyb symbol
Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Mohammed M. Wahman symbol
Department of Clinical Oncology, South Valley University, Qena, Egypt

Asmaa Nafady Email symbol
Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt

Citation


Zahran AM, Nafady-Hego H, Moeen SM, Eltyb HA, Wahman MM, Nafady A. Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. Afr J Lab Med. 2022;11(1), a1713. https://doi.org/10.4102/ajlm.v11i1.1713

Note: DOI of original article published: https://doi.org/10.4102/ajlm.v10i1.1296.

Correction

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker

Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady

Published: 25 Mar. 2022

Copyright: © 2022. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the published article, Zahran AM, Nafady-Hego H, Moeen SM, Eltyb HA, Wahman MM, Nafady A. Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. Afr J Lab Med. 2021;10(1), a1296. https://doi.org/10.4102/ajlm.v10i1.1296, there was an error on page 3 under the ‘Results’ section. The mean age of the MM patients should be 63.5 as per Table 1 instead of 6.35. The first paragraph under the ‘Results’ section is updated to:

Results

Baseline characteristics of newly diagnosed multiple myeloma patients and healthy controls

The mean age of the MM patients was 63.5 ± 4.07 years, and the number of men (13) was double that of women (7) (Table 1). The proportion of plasma cells in bone marrow was 39.7% ± 3.7% and that of the monoclonal band (M-protein) was 4.44 g/dL ± 2.8 g/dL.

The authors apologise for this error. The correction does not change the study’s findings of significance or overall interpretation of the study’s results or the scientific conclusions of the article in any way.